{
    "title": "105_s2347",
    "content": "The Act is titled the \"Comprehensive Methamphetamine Abuse Reduction Act\" and aims to expand prevention efforts for methamphetamine abuse. The Comprehensive Methamphetamine Abuse Reduction Act expands prevention efforts by allowing grants for school-based programs on methamphetamine abuse and addiction. The Comprehensive Methamphetamine Abuse Reduction Act allows public and non-profit private entities to implement school-based and community-based programs to prevent methamphetamine abuse. Funding from grants, contracts, or cooperative agreements must be used for planning and administering these programs. The Comprehensive Methamphetamine Abuse Reduction Act allows funding for community-based prevention programs that are evidence-based. Funds must be used for planning and administering methamphetamine prevention programs, including school-based initiatives. Funds under the Comprehensive Methamphetamine Abuse Reduction Act can be used for school-based programs targeting districts with high methamphetamine abuse rates and populations at risk of starting methamphetamine abuse. The Comprehensive Methamphetamine Abuse Reduction Act funds school-based and community-based programs targeting districts with high methamphetamine abuse rates and populations at risk. The Comprehensive Methamphetamine Abuse Reduction Act funds community-based prevention programs focused on at-risk populations, assists local government entities in prevention activities, and educates law enforcement officials on signs of abuse and addiction. The Comprehensive Methamphetamine Abuse Reduction Act funds prevention activities for local government entities, educates law enforcement officials on signs of abuse, and supports planning and educational activities for prevention. The Comprehensive Methamphetamine Abuse Reduction Act funds prevention activities, educates law enforcement, supports planning, monitoring, and evaluation of prevention efforts, and implements targeted pilot programs. The Director prioritizes grants for methamphetamine prevention activities in rural and urban areas with high rates of addiction. Grants support monitoring, evaluation, reporting, and pilot programs to encourage innovation. The Director gives priority to grants for methamphetamine prevention in areas with high addiction rates. Not less than $500,000 annually is allocated for analyses and evaluation to encourage innovation. The Director prioritizes grants for methamphetamine prevention in high addiction rate areas. At least $500,000 annually is allocated for analyses and evaluations to support effective prevention programs and dissemination strategies. The Director prioritizes grants for methamphetamine prevention in high addiction rate areas, allocating at least $500,000 annually for analyses and evaluations of prevention programs. The Director also submits annual reports to relevant Senate and House committees on the results of these analyses and evaluations. The Director allocates funds for methamphetamine prevention programs in high addiction rate areas, with annual reports submitted to Senate and House committees. Authorization of appropriations is set at $20,000,000 for fiscal year 1999 and may vary for succeeding years. SEC. 3. EXPANDING CRIMINAL PENALTIES AND LAW ENFORCEMENT FUNDING. The United States Sentencing Commission will create or adjust sentencing guidelines for offenses related to the manufacture of amphetamine or methamphetamine in violation of the Controlled Substances Act. The United States Sentencing Commission will create or adjust sentencing guidelines for offenses related to the manufacture of amphetamine or methamphetamine in violation of the Controlled Substances Act, the Controlled Substances Import and Export Act, or the Maritime Drug Law Enforcement Act. The United States Sentencing Commission will adjust sentencing guidelines for offenses related to the manufacture of amphetamine or methamphetamine in violation of certain acts. This includes increasing the base offense level by at least 3 levels. The United States Sentencing Commission will increase the base offense level for offenses related to the manufacture of amphetamine or methamphetamine by at least 3 levels. The United States Sentencing Commission will increase the base offense level for offenses related to the manufacture of amphetamine or methamphetamine to a minimum of level 27 if the offense poses a substantial risk to another person's health and safety. The base offense level for offenses related to the manufacture of amphetamine or methamphetamine will be increased to at least level 27 if there is a substantial risk to another person's health and safety. Additionally, if the offense poses a danger to law enforcement officers, the offense level will be increased by at least 6 levels. The base offense level for offenses related to the manufacture of amphetamine or methamphetamine will be increased by at least 6 levels if there is a substantial risk to another person's health and safety. If the resulting base offense level after the increase would be less than level 30, it will be set to level 30. The United States Sentencing Commission will promptly establish guidelines or amendments following the enactment of this Act. The United States Sentencing Commission will promptly establish guidelines or amendments following the enactment of this Act for offenses occurring on a level below 30. The amendments made pursuant to this subsection under the Sentencing Act of 1987 will apply to offenses occurring 60 days after the enactment of this Act. Increased resources are authorized for the Office of National Drug Control Policy to combat methamphetamine trafficking in designated high intensity drug trafficking areas. Increased resources are authorized for the Office of National Drug Control Policy to combat methamphetamine trafficking in designated high intensity drug trafficking areas. $25,000,000 is authorized for fiscal year 1999, and necessary sums for fiscal years 2000 through 2004. SEC. 4. Treatment of methamphetamine abuse. Section 507 of the Public Health Service Act is amended to allow grants for the treatment of methamphetamine abuse and addiction by the Director of the Center for Substance Abuse Treatment. The Director of the Center for Substance Abuse Treatment may provide grants and contracts to public and non-profit entities to expand methamphetamine treatment programs. Funds must be used for planning, establishing, or administering treatment programs in accordance with specified guidelines. The Director of the Center for Substance Abuse Treatment may provide grants and contracts for methamphetamine treatment programs. Funds can be used for evidence-based programs to help individuals quit methamphetamine use and for training in recognizing methamphetamine abuse. The subsection allows for evidence-based programs to help individuals quit methamphetamine use, training for health professionals in recognizing methamphetamine abuse and addiction, and training in methamphetamine treatment methods for health plans. Training in methamphetamine treatment methods is provided for various health professionals, including physicians, nurses, dentists, and public health educators. This includes planning, administration, and educational activities related to treatment. Health professionals, including physicians, nurses, dentists, and public health educators, are involved in planning, administering, and educating on methamphetamine treatment. They also monitor and evaluate treatment activities, and report information to the public. The curr_chunk focuses on monitoring and evaluating methamphetamine treatment activities, implementing pilot programs for innovation, and coordinating with the Center for Mental Health Services. The Director prioritizes grants for rural and urban areas with high rates of methamphetamine abuse, focusing on innovation and coordination with the Center for Mental Health Services. The Director gives priority in grants to rural and urban areas with high rates of methamphetamine abuse. Up to $1,000,000 is allocated each fiscal year for analyses and evaluation. The Director prioritizes grants for urban areas with high rates of methamphetamine abuse. Up to $1,000,000 is allocated annually for evaluations of effective treatments and strategies for addiction. The Director, in consultation with other agencies, uses funds for periodic analyses on methamphetamine treatment effectiveness and dissemination strategies. Annual reports are submitted to specific Senate committees. The Director uses funds for analyses on methamphetamine treatment effectiveness and dissemination strategies. An annual report is submitted to specific Senate committees. Authorization of appropriations is set at $40,000,000. The Director submits an annual report to specific Senate committees on methamphetamine treatment effectiveness and dissemination strategies. Authorization of appropriations is set at $40,000,000 for fiscal year 1999 and succeeding years. SEC. 5. EXPANDING METHAMPHETAMINE RESEARCH. Section 464N of the Public Health Service Act is amended to allow grants for interdisciplinary research on methamphetamine abuse and addiction, as well as other related issues. The grants can be used to conduct research on various aspects of methamphetamine abuse and addiction. The amended Section 464N of the Public Health Service Act allows grants for interdisciplinary research on methamphetamine abuse and addiction. The funds can be used for research on the effects of methamphetamine abuse on the human body, the addictive nature of methamphetamine, and the connection between methamphetamine abuse. Research on the effects of methamphetamine abuse on the human body, the addictive nature of methamphetamine, differences in effects among individuals, the connection between methamphetamine abuse and mental illness, effective prevention methods, and treatment approaches. The curr_chunk focuses on identifying effective prevention methods, treatment approaches, risk factors, and effects of methamphetamine abuse on pregnant women and their fetuses. The curr_chunk discusses pharmacological treatments, risk factors, effects on pregnant women and fetuses, and reasons for methamphetamine abuse. The Director will disseminate research results to combat methamphetamine abuse. The Director will disseminate research results on methamphetamine abuse to relevant entities. Authorization of appropriations is provided for funding."
}